News, Short Squeeze, Breakout and More Instantly...
bluebird bio (NASDAQ: BLUE) ran into some issues with manufacturing its gene therapy, and then the drugmaker was sideswiped by the possibility that its treatment might cause cancer. In this video from Motley Fool Live , recorded on Mar ch 22 , Fool.com contributo...
Top Health Care Stocks To Buy [Or Sell] Right Now Health care stocks continue to show long-term value for investors in the stock market . One of the reasons could be that health care is always in demand. Health care companies provide and sell a wide range of products aft...
Shares of bluebird bio (NASDAQ: BLUE) have been on a roller coaster ride recently as the company faced the potential that its gene therapy could cause cancer. In this video from Motley Fool Live , recorded on Mar ch 15 , Fool.com contributors Brian Orelli and Kei...